GlassScriptPhysician profile
Gail B Whitman
NPI 1043288061
$8,208.10
in general payments reported to CMS, 2019-2025
35 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,524 · 2020: $728 · 2021: $1,530 · 2022: $1,270 · 2023: $1,350 · 2024: $1,008 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,958 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,957.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $199.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,382.44 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $793.91 | 2019-2025 | Cabtreo, Jublia |
| Pfizer INC. | $589.96 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $410.50 | 2019-2025 | Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $398.05 | 2019-2023 | Aklief |
| Dermavant Sciences, INC. | $387.50 | 2023-2024 | Vtama |
| Abbvie INC. | $376.71 | 2019-2025 | |
| Janssen Biotech, INC. | $372.62 | 2020-2025 | Tremfya, Simponi, Simponi Aria |
| Mayne Pharma Commercial LLC | $335.89 | 2019-2025 | |
| Amgen INC. | $334.52 | 2019-2025 | Otezla, Otezla |
| Incyte Corporation | $323.34 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $305.53 | 2021-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $278.81 | 2019-2021 | |
| Dermira, INC. | $240.90 | 2019-2021 | |
| Genzyme Corporation | $234.15 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $180.36 | 2019-2024 | |
| Organon LLC | $151.94 | 2025 | Vtama |
| Lilly USA, LLC | $145.12 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Arcutis Biotherapeutics, INC. | $137.27 | 2023-2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $136.77 | 2020 | |
| Almirall LLC | $132.72 | 2019-2021 | |
| Epi Health, LLC | $117.26 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $108.36 | 2021-2025 | |
| Encore Dermatology INC. | $60.73 | 2019 | |
| Biofrontera INC. | $45.10 | 2022 | |
| Aclaris Therapeutics, INC. | $42.81 | 2019 | |
| Verrica Pharmaceuticals INC. | $37.35 | 2024 | Ycanth |
| Genentech USA, INC. | $34.35 | 2024 | Xolair |
| Glenmark Therapeutics INC. | $21.00 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $19.02 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.72 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.62 | 2024 | Sotyktu |
| Strata Skin Sciences, INC. | $13.19 | 2024 | Xtrac |
| Celgene Corporation | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Whitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.